首页> 外文期刊>clinical nuclear medicine >Tc-99m MIBI, Tc-99m Tetrofosmin, and Tc-99m (V) DMSA Accumulation in Recurrent Malignant Thymoma
【24h】

Tc-99m MIBI, Tc-99m Tetrofosmin, and Tc-99m (V) DMSA Accumulation in Recurrent Malignant Thymoma

机译:Tc-99m MIBI, Tc-99m Tetrofosmin, and Tc-99m (V) DMSA Accumulation in Recurrent Malignant Thymoma

获取原文
           

摘要

Thymoma is the most common primary tumor of the anterior mediastinum, accounting for 20percnt; to 30percnt; of all mediastinal tumors. The recurrence rate after total resection of the thymoma ranges from 8percnt; to 18percnt;. The authors describe a patient with recurrent malignant thymoma imaged with Tc-99m MIBI, Tc-99m tetrofosmin, and Tc-99m (V) DMSA. Early and delayed Tc-99m MIBI and Tc-99m tetrofosmin scintigraphy showed increased uptake in the mediastinal area, as did Tc-99m (V) DMSA scintigraphy. Coronal SPECT images obtained with Tc-99m MIBI, Tc-99m tetrofosmin, and Tc-99m (V) DMSA showed increased uptake in the mediastinal lesion seen on a computed tomograph of the chest. However, the normal blood-pool activity of the heart and great vessels imaged with Tc-99m (V) DMSA obscured the recurrent malignant thymoma. Although Tc-99m (V) DMSA is a useful tumor-seeking agent, Tc-99m MIBI and Tc-99m tetrofosmin SPECT are preferred to Tc-99m (V) DMSA to detect primary and recurrent malignant thymoma.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号